Let’s start with the basics: All cannabinoids in hemp come from cannabigerolic acid (CBGa).
Plant enzymes then turn CBGa into a combination of the three major cannabinoid precursors: tetrahydrocannabinolic acid (THCA), cannabichromenic acid (CBCA), and cannabidiolic acid (CBDA). The combination will depend on the strain of hemp they are derived from.
CBDA is a non-psychoactive compound that acts as a precursor to CBD. More specifically, CBDA is heated to create CBD, for instance when the plant is left to dry. For this reason, CBDA is considered raw CBD. CBDA is most often found in the live or raw hemp plants.
Cannabidiolic acid is often consumed as CBD, but it can also be beneficial in its raw form. CBDA oil can be consumed or absorbed via tinctures, raw cannabis juice, topical creams, and raw CBDA oil.
While research in CBDA is in much earlier stages than even CBD, we know that they are both non-psychoactive, meaning users won’t get high or stoned. This is because CBD and CBDA both do not directly interact with our endocannabinoid receptors, but by activating our 5-HT1A serotonin receptors. Serotinin is a neurotransmitter that is regulating our mood, sleep, anxiety, appetite and nausea.
CBD is widely being researched for its effectiveness against sleep problem, anxiety, depression and inflammation. Meanwhile, CBDA is in the very early stages of research but shows just as much, if not more, promise than CBD. We cannot make any medical claims until the data is in, but we are setting up an observational study that compares CBD and CBDA, which we hope to share more about soon.
In the meantime we are proud to have developed unique formulations that combine CBD, CBDA and other active ingredients, to optimize its effectiveness. And these state-of-the-art formulations are available for you!